Results 181 to 190 of about 9,107,460 (340)

Shifting sands in Saudi Arabian healthcare system towards value-based care: navigating the changing landscape. [PDF]

Front Public Health
Al-Jedai A, Almudaiheem H, Aburas WIS, Almutairi E, Eshmawi MT, Al Sulaiman K, Tawfik E, Al-Luhidan M, Alowairdhi M, Awad N, Ojeil R, Alshennawi MA.   +11 more
europepmc   +1 more source

High Health Care Spending and Developing Technology: Proton Beam Therapy [PDF]

, 2020
Han, Yoojeong Jaye
core   +1 more source

Challenges and Solutions in Deploying Systematized Nomenclature of Medicine—Clinical Terms in the Chinese Healthcare Context

Health Care Science, EarlyView.
ABSTRACT Systematized nomenclature of medicine—clinical terms (SNOMED CT), one of the most comprehensive clinical terminology systems, is pivotal in enhancing healthcare interoperability, clinical data governance, and medical artificial intelligence (AI) development globally.
Ge Wu, Jiale Nan, Yanmei Chen, Chao Liu, Taotao Fu, Xudong Lu, Yani Chen, Zhirong Zeng, You Wu, Mengchun Gong   +9 more
wiley   +1 more source

Medical security for rare disease patients in China: Insights from patients with Dravet syndrome. [PDF]

Intractable Rare Dis Res
Wu J, Lu X, Gu L, Yang Y, Zhang M, Zhou H, Zhou L, Lan Y, Li J, Mao N.   +9 more
europepmc   +1 more source

Disparity in the Markers of Affordability Across Targeted‐ and Immune‐Therapy Drugs Used in Head and Neck Cancers

Head &Neck, EarlyView.
ABSTRACT Background The expanding use of systemic therapies for recurrent and metastatic head and neck cancer has raised major concerns regarding affordability and equitable access, particularly across countries with differing income levels and health financing structures.
Arjun Gurmeet Singh, Labani Kole, Richard Sullivan, Shwetabh Sinha, Rathan Shetty, Poonam Joshi, Sudhir Nair, Sarbani Ghosh Laskar, Kumar Prabhash, Pankaj Chaturvedi   +9 more
wiley   +1 more source

Health technology assessment and medical insurance access for rare disease drugs in China: A policy review with quantitative insights from publicly available data. [PDF]

Intractable Rare Dis Res
Ai D, Sui B, Duan C, Liu Z, Zhang F, Zhao K.   +5 more
europepmc   +1 more source

AKT, ATR, and Notch Inhibitors Radiosensitize a Preclinical Model of Adenoid Cystic Carcinoma

Head &Neck, EarlyView.
ABSTRACT Background Adenoid Cystic Carcinoma (ACC) is a rare and lethal type of head and neck cancer. Standard therapy involves surgery followed by radiation therapy. The majority of ACC has MYB overexpression and MYB‐NFIB gene fusions, while Notch mutations are associated with aggressive behavior.
Shivani Thoidingjam, Sushmitha Sriramulu, Asya Haider Muratoglu, Stephen Brown, Oudai Hassan, Benjamin Movsas, Haythem Ali, Steven Chang, Patrick Ha, Farzan Siddiqui, Shyam Nyati   +10 more
wiley   +1 more source

Public procurement of cardiac implantable electronic devices across Europe: are we purchasing value or cost-effectiveness? [PDF]

Europace
Osoro L, Arbelo E, Kozhuharov N, Landen R, Martinek M, Leclerq C, Fauchier L, De Haro JC, Boveda S, Sommer P, Rienstra M, Symanski P, Farkowski M, Egorova A, Moscoso Costa F, Tint D, Simovic S, Dzhinsov K, Leyva F, Boriani G, Figueras J, Ihara Z, Merino JL, Burri H, Pürerfellner H, Casado-Arroyo R.   +25 more
europepmc   +1 more source

The single market in pharmaceuticals. Communication from the Commission. COM (98) 588 final, 25 November 1998 [PDF]

, 1998

core  

Nationwide Study on the Cervical Cancer Screening Pathway in Estonia

International Journal of Cancer, EarlyView.
Cervical cancer remains a significant burden despite being preventable, largely due to inadequate screening participation and poor follow‐up of high‐risk women. Here, the authors investigated follow‐up rates among women who tested positive for high‐risk human papillomavirus (hr‐HPV) infection in primary screening in Estonia. Data show that more than 57
Aleksandra Šavrova, Helen Jakoby, Anna Tisler, Kaire Innos, Ülo Maiväli, Jana Jaal, Anneli Uusküla   +6 more
wiley   +1 more source